Pharma, Biotech and Generics Industry News | The Pharmaletter
WEB11 September 2024 NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s. More Insights >.
Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >. 24 September 2024. 22 September 2024.
Special Reports - The Pharma Letter
WEBJun 17, 2020 · Our latest Special Report is a review of key factors impeding progress of US biosimilar adoption written by Helen Ji, an associate at Schiff Hardin LLP, Rekha Hanu, executive director and chief IP counsel at Akorn Pharmaceuticals and Christine Simmon, SVP for policy and strategic alliances at the Association for Accessible Medicines. 4 …
ILTOO Pharma | Biotechnology - The Pharmaletter
WEBILTOO Pharma. A French clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). ILTOO Pharma is developing regulatory T cell-mediated immunotherapies. Its lead product, ILT-101 (Aldesleukin ...
About The Pharma Letter | The Pharmaletter
WEB2 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Schering: Betaferon - Pharmaceutical industry news | The …
WEBSchering: Betaferon. 25 June 1995. - Schering Pty Ltd, the Australian subsidiary of Germany's Schering AG, has received approval in its home market for Betaferon (interferon beta). Australia becomes the second country to approve the drug, for relapsing-remitting multiple sclerosis, after the USA in 1993. European registration is expected shortly.
Pharma M&A news | The Pharmaletter
WEBSep 18, 2024 · Fosun Pharma secures full ownership of Fosun Kite with $27 million deal. Shanghai-based Fosun Pharmaceutical has announced it has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 million, giving it full control of the joint venture. 23 September 2024. Pharmaceutical.
CROs keep growing, as Tigermed acquires Tokyo firm
WEBJul 31, 2024 · This article is accessible to registered users, to continue reading please register for free.. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the …
Pharma News and Insights Podcast | The Pharmaletter
WEBJul 17, 2023 · The Pharma Letter Podcast — Episode 22 — A new way to innovate, from Flagship Pioneering. Flagship Pioneering has had an outsized impact on the sector, launching a spate of successful biotechs, including Moderna Therapeutics. Now, with Pioneering Medicines, the group hopes to shake things up again. 20 April 2023.
Humanwell Healthcare and PuraCap to acquire Epic Pharma
WEBGenerics. 8 April 2016. China-based Humanwell Healthcare Group and PuraCap Pharmaceutical have entered into a definitive agreement to acquire 100% of privately-held US generic drugs marker Epic Pharma. The acquisition, which involves a payment of $550 million, will further establish Humanwell and PuraCap in …